Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Medical Properties Trust MPW in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 0 | 2 | 1 | 1 |
Last 30D | 0 | 0 | 0 | 0 | 1 |
1M Ago | 0 | 0 | 1 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 1 | 1 | 0 |
Analysts have recently evaluated Medical Properties Trust and provided 12-month price targets. The average target is $4.62, accompanied by a high estimate of $7.00 and a low estimate of $2.00. This current average represents a 52.22% decrease from the previous average price target of $9.67.
Decoding Analyst Ratings: A Detailed Look
In examining recent analyst actions, we gain insights into how financial experts perceive Medical Properties Trust. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Omotayo Okusanya | Deutsche Bank | Announces | Sell | $2.00 | - |
Vikram Malhotra | Mizuho | Lowers | Neutral | $7.00 | $9.00 |
Michael Lapides | JP Morgan | Lowers | Underweight | $5.00 | $8.00 |
Stephen Manaker | Stifel | Lowers | Hold | $4.50 | $12.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Medical Properties Trust. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Medical Properties Trust compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Medical Properties Trust's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Medical Properties Trust's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Medical Properties Trust analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
About Medical Properties Trust
Medical Properties Trust Inc is a healthcare facility REIT. The company operates one segment, which owns and leases healthcare facilities. The vast majority of Medical's revenue is generated in the United States, followed by Germany and the United Kingdom. The company considers merger and acquisition investment as a component of its operational growth strategy. It provides financing for a variety of facilities that require funds for acquisitions, sale-leasebacks, new developments, and expansion projects.
Key Indicators: Medical Properties Trust's Financial Health
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Medical Properties Trust's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2023, the company experienced a revenue decline of approximately -12.99%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: Medical Properties Trust's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 37.97%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 1.4%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Medical Properties Trust's ROA stands out, surpassing industry averages. With an impressive ROA of 0.61%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 1.24, Medical Properties Trust adopts a prudent financial strategy, indicating a balanced approach to debt management.
The Basics of Analyst Ratings
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.